Abstract
Radiotherapy is the common traditional treatment for non-small cell lung cancer (NSCLC). In recent years, remarkable advances have been made in immunotherapy, especially the use of immune checkpoint inhibitors. How to effectively combine radiotherapy and immunotherapy to maximize the benefit for patients has become a hot topic in clinical research. This article expounds recent research progress in immunotherapy for NSCLC, the effect of radiotherapy on tumor immunology, and the advances and challenges in radiotherapy combined with immunotherapy for NSCLC. Key words: Carcinoma, non-small cell lung/radiotherapy; Carcinoma, non-small cell lung/immunotherapy; Research progress
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
